Search hospitals
>
Illinois
>
Chicago
Rush University Medical Center
Claim this profile
Chicago, Illinois 60612
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Parkinson's Disease
Conducts research for HIV Infection
Conducts research for Ovarian Cancer
1654 reported clinical trials
119 medical researchers
Summary
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Parkinson's Disease, HIV Infection, Ovarian Cancer and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,583 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and James Moy, MD.
Area of expertise
Lung Cancer
Rush University Medical Center has run 81 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Rush University Medical Center has run 76 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Alan Tan
Rush University Medical Center
5 years of reported clinical research
Dian Wang, MD, PhD
Rush University Medical Center
8 years of reported clinical research
Timothy M Kuzel, MD
Rush University Medical Center
9 years of reported clinical research
James Moy, MD
Rush University Medical Center
5 years of reported clinical research
Clinical Trials running at Rush University Medical Center
Skin Cancer
Prostate Cancer
Breast Cancer
Rett Syndrome
Lung Cancer
Testicular cancer
Small Cell Lung Cancer
Cancer
Kidney Cancer
Intellectual Disability
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting
2 awards
Phase 3
7 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Neoadjuvant Daromun + Surgery
for Melanoma
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C/D melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting
2 awards
Phase 3
18 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rush University Medical Center?
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Parkinson's Disease, HIV Infection, Ovarian Cancer and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,583 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and James Moy, MD.
Where is Rush University Medical Center located?
Rush University Medical Center is conveniently situated at 1620 W. Harrison St., Chicago, IL 60612, easily accessible from the Eisenhower Expressway (I-290) and just five minutes west of Chicago's Loop. Public transportation options include two nearby Chicago Transit Authority (CTA) train stations: Illinois Medical District (Blue Line) and Polk (Pink Line). Additionally, the area is served by several CTA bus routes: #7 Harrison, #9 Ashland, #126 Jackson, and #157 Streeterville/Taylor.
Who should I call to ask about financial aid or insurance network?
**Rush University Medical Center Financial Assistance and Insurance Information:** - **Financial Assistance:** Contact at (312) 942-5693 or (866) 761-7812, or email billing_info@rush.edu. Office hours are Monday through Friday, 8 a.m. to 4:30 p.m. - **Insurance Inquiries:** Contact the Insurance Department at (630) 978-2532 or visit [www.vnahealth.com](http://www.vnahealth.com). Address: VNA Health Center, 400 N. Highland Ave., Aurora, IL 60506.
What insurance does Rush University Medical Center accept?
Rush University Medical Center accepts a wide range of insurance plans, including HMO, POS, and PPO. RUSH Copley Medical Group specifically accepts commercial and governmental plans such as Aetna, Blue Cross/Blue Shield, Cigna, Humana, Medicare Part B, Medicare Advantage, Tricare, and United Healthcare. Short-term health insurance plans with PPO networks like Aetna or Cigna also typically provide coverage at Rush.
What awards or recognition has Rush University Medical Center received?
Rush University Medical Center, located in Chicago, Illinois, is renowned for its exceptional research and care. It has been designated as a Center of Excellence for Parkinson's Disease Program by the Parkinson's Foundation and a National Pancreas Foundation Center of Excellence for Pancreatic Cancer. The hospital also boasts accreditations from prestigious organizations including the American College of Surgeons' Commission on Cancer, the Foundation for the Accreditation of Cellular Therapy, and the American College of Radiology, highlighting its dedication to high-quality care and patient safety.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.